X2S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 2.033 EUR Market Closed

Market Cap: €2.7B

S	Sinopharm Group Co Ltd XMUN:X2S	CN
A	Ares Capital Corp F:9A2	US
L	Lowe's Companies Inc F:LWE	US
R	Relx PLC XMUN:RDEB	UK
F	Fortress Biotech Inc F:CNB	US
T	Telefonaktiebolaget LM Ericsson DUS:ERCB	SE
	Cantaloupe Inc F:UTE0	US
	Japfa Comfeed Indonesia Tbk PT F:1JC1	ID
M	Melia Hotels International SA XMUN:MEL	ES
I	Industrial and Commercial Bank of China Ltd XBER:ICK	CN
S	Shin-Etsu Chemical Co Ltd XMUN:SEH	JP
	Henkel AG & Co KGaA F:HEN3	DE

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

9% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

3% > 3%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.